Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

لقطات الشاشة لـ AnticoagEvaluator

iPad

iPhone

About AnticoagEvaluator

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

تحديث لأحدث إصدار 4.1

Last updated on 15/12/2023

الإصدارات القديمة

Bug fixes

Version History

4.1

15/12/2023

Bug fixes

4.0

08/09/2023

This update includes underlying architecture improvements and minor reference link updates.

3.0

30/01/2019

This version includes the following:
1) 2019 AFib Guideline Update content
2) Design updates

2.3

22/05/2017

• Updated stroke risk values on no therapy in accordance with ACC/AHA Guidelines.
• Additional reference information on risk calculations.

2.2

01/09/2016

Updated warfarin dosing information.

2.0

16/12/2015

•Edoxaban added to the list of available therapies
•App provides therapy selection advice from the ACC/AHA/HRC Atrial Fibrillation Guideline.
•App includes the Cockcroft-Gault creatinine clearance calculator and provides renal-function adjusted dosing for the novel oral anticoagulants
•The overall App has been updated to have a smoother look and feel based on user feedback

1.4.1

13/12/2014

Bug Fix

1.4

10/12/2014

Updated for iOS8
Optimized for iPad Air, iPhone 6 and iPhone 6 Plus

1.3.59

15/08/2014

Cosmetic changes

1.3

14/07/2014

IOS7 ready

1.1

04/06/2013

Copy edits and small bug fixes

Email functionality added. Click to email results.

About this App Tab added to results page

Score chart added to calculator and results pages.

Ability to click on entire item in Calculator, not just checkbox.

iPhone functionality to come in the next update!

1.0

06/03/2013

Feedback Report